comparemela.com

Latest Breaking News On - Molecular guidance system - Page 1 : comparemela.com

N4 Pharma collaborates with SRI International to combine Nuvec and FOX Three MGS technology

N4 Pharma Plc partners with SRI International to combine Nuvec® with FOX Three MGS, aiming to enhance nucleotide therapies for cancer and vaccines.

Collaboration Agreement with SRI International Inc | Company Announcement

FOX Three Molecular Guidance System: A Novel Platform for Targeted Intracellular Delivery of Biotherapeutics, Upcoming Webinar Hosted by Xtalks

FOX Three Molecular Guidance System: A Novel Platform for Targeted Intracellular Delivery of Biotherapeutics, Upcoming Webinar Hosted by Xtalks Share Article In this free webinar, the featured speaker will discuss molecular guidance systems, or MGSs, and how they can be rapidly identified for virtually any cell type. MGSs can deliver a wide variety of cargoes, ranging from small molecules to full length antibodies, and can achieve cell specific and subcellular specific delivery. MGS conjugates can reach high intracellular concentrations in the target cell resulting in biological efficacy. FOX Three utilizes highly diverse, phage-displayed peptide libraries to rapidly identify MGSs. TORONTO (PRWEB)

Xtalks Announces Its Life Science Webinar Calendar for June 2021

Xtalks Announces Its Life Science Webinar Calendar for June 2021 Share Article Upcoming free, educational webinars from Xtalks Webinars will feature topics on biomarkers, clinical trials, drug discovery & development, healthcare, laboratory technology, patient recruitment & retention, pharmaceutical, pharma manufacturing & supply chain, medical devices and food. TORONTO (PRWEB) June 01, 2021 Stay on top of current hot topics through free webinars presented by leading experts in pharma, biotech, medical device and food industries. Access to all webinars is free, so be sure to register today to save your place! Participate in the discussion and stay relevant in your field! Visit http://www.xtalks.com to see our upcoming webinars:

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.